IS4130A - Ný fjölpeptíð - Google Patents
Ný fjölpeptíðInfo
- Publication number
- IS4130A IS4130A IS4130A IS4130A IS4130A IS 4130 A IS4130 A IS 4130A IS 4130 A IS4130 A IS 4130A IS 4130 A IS4130 A IS 4130A IS 4130 A IS4130 A IS 4130A
- Authority
- IS
- Iceland
- Prior art keywords
- bssl
- variant
- new polypeptide
- characterization
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20041—Use of virus, viral particle or viral elements as a vector
- C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Environmental Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Husbandry (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Biodiversity & Conservation Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9300686A SE9300686D0 (sv) | 1993-03-01 | 1993-03-01 | Novel polypeptides |
| SE9300722A SE9300722D0 (sv) | 1993-03-04 | 1993-03-04 | Novel polypeptides ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4130A true IS4130A (is) | 1994-09-02 |
Family
ID=26661673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4130A IS4130A (is) | 1993-03-01 | 1994-02-11 | Ný fjölpeptíð |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US5827683A (is) |
| EP (1) | EP0687296B1 (is) |
| JP (1) | JP3837444B2 (is) |
| KR (2) | KR100312825B1 (is) |
| CN (2) | CN1071790C (is) |
| AT (1) | ATE317429T1 (is) |
| AU (1) | AU675701B2 (is) |
| BR (1) | BR9406376A (is) |
| CA (1) | CA2156083C (is) |
| CZ (1) | CZ290927B6 (is) |
| DE (1) | DE69434622T2 (is) |
| DK (1) | DK0687296T3 (is) |
| EE (1) | EE9400458A (is) |
| ES (1) | ES2258262T3 (is) |
| FI (1) | FI954082L (is) |
| HU (1) | HU221119B1 (is) |
| IL (2) | IL108698A0 (is) |
| IS (1) | IS4130A (is) |
| NO (1) | NO953426D0 (is) |
| NZ (1) | NZ262529A (is) |
| PL (1) | PL184960B1 (is) |
| PT (1) | PT687296E (is) |
| RU (1) | RU2219239C2 (is) |
| SG (1) | SG52597A1 (is) |
| SK (1) | SK285420B6 (is) |
| TW (1) | TW387013B (is) |
| UA (1) | UA48109C2 (is) |
| WO (1) | WO1994020610A1 (is) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681819A (en) * | 1994-12-01 | 1997-10-28 | Oklahoma Medical Research Foundation | Method and compositions for reducing cholesterol absorption |
| US5696087A (en) * | 1994-12-01 | 1997-12-09 | Oklahoma Medical Research Foundation | Method and compositions for reducing cholesterol absorption |
| JP3007161B2 (ja) * | 1994-12-01 | 2000-02-07 | オクラホマ メディカル リサーチ ファウンデーション | コレステロール吸収を減少するための方法および組成物 |
| US5821226A (en) * | 1994-12-01 | 1998-10-13 | Oklahoma Medical Research Foundation | BAL C-tail drug delivery molecules |
| FR2733249B1 (fr) * | 1995-04-20 | 1997-06-06 | Biocem | Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations |
| SE9501939D0 (sv) * | 1995-05-24 | 1995-05-24 | Astra Ab | DNA molecules for expression of polypeptides |
| US6342218B1 (en) | 1997-02-14 | 2002-01-29 | Oklahoma Medical Research Foundation | Method for treatment of SLE |
| SE9801424D0 (sv) * | 1998-04-22 | 1998-04-22 | Astra Ab | Expression methods |
| AU2001255469A1 (en) * | 2000-04-21 | 2001-11-07 | Monsanto Technology Llc | Purification of ace inhibiting polypeptides containing vpp from milk |
| EP1730270B1 (fr) | 2004-03-31 | 2016-03-30 | Université d'Aix-Marseille | Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique |
| FR2868424B1 (fr) * | 2004-03-31 | 2008-04-11 | Univ Aix Marseille Ii | Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique |
| CN100343391C (zh) * | 2004-12-31 | 2007-10-17 | 中国农业大学 | 卵巢注射法制备转基因动物 |
| EP2039764A1 (en) * | 2007-09-19 | 2009-03-25 | Pevion Biotech AG | Truncated secretory aspartyl proteinase 2 |
| WO2012052060A1 (en) | 2010-10-21 | 2012-04-26 | Swedish Orphan Biovitrum Ab (Publ) | Method to increase the growth velocity of human infants |
| JP5800907B2 (ja) | 2010-10-21 | 2015-10-28 | スウェディッシュ オーファン バイオビトラム パブリーク アクチエボラグ | ヒト乳児による不飽和脂肪酸の吸収を増大させる方法 |
| FR2966734B1 (fr) | 2010-10-29 | 2014-07-18 | Max Rombi | Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides |
| AU2012256449B2 (en) * | 2011-05-18 | 2015-04-09 | Swedish Orphan Biovitrum Ab (Publ) | Low pH protein purification process |
| CN103088000A (zh) * | 2012-03-23 | 2013-05-08 | 北京济福霖生物技术有限公司 | 在哺乳动物乳腺中过表达胆盐激活脂酶的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200183A (en) * | 1987-11-19 | 1993-04-06 | Oklahoma Medical Research Foundation | Recombinant bile salt activated lipases |
| US4944944A (en) * | 1987-11-19 | 1990-07-31 | Oklahoma Medical Research Foundation | Dietary compositions and methods using bile salt-activated lipase |
| US5204134A (en) * | 1989-01-13 | 1993-04-20 | Immuno Path Profile, Inc. | Hypoallergenic milk products from natural and/or synthetic components and process of making |
| SE9001985D0 (sv) * | 1990-06-01 | 1990-06-01 | Astra Ab | New chemical products |
-
1994
- 1994-02-11 IS IS4130A patent/IS4130A/is unknown
- 1994-02-17 IL IL10869894A patent/IL108698A0/xx not_active IP Right Cessation
- 1994-02-17 IL IL144015A patent/IL144015A/en not_active IP Right Cessation
- 1994-02-19 TW TW083101413A patent/TW387013B/zh not_active IP Right Cessation
- 1994-02-25 DE DE69434622T patent/DE69434622T2/de not_active Expired - Lifetime
- 1994-02-25 CZ CZ19952169A patent/CZ290927B6/cs not_active IP Right Cessation
- 1994-02-25 SK SK1085-95A patent/SK285420B6/sk not_active IP Right Cessation
- 1994-02-25 ES ES94909373T patent/ES2258262T3/es not_active Expired - Lifetime
- 1994-02-25 NZ NZ262529A patent/NZ262529A/en not_active IP Right Cessation
- 1994-02-25 CN CN94191848A patent/CN1071790C/zh not_active Expired - Lifetime
- 1994-02-25 CA CA002156083A patent/CA2156083C/en not_active Expired - Lifetime
- 1994-02-25 HU HU9502561A patent/HU221119B1/hu unknown
- 1994-02-25 PL PL94310413A patent/PL184960B1/pl unknown
- 1994-02-25 KR KR1019950703676A patent/KR100312825B1/ko not_active Expired - Lifetime
- 1994-02-25 AT AT94909373T patent/ATE317429T1/de active
- 1994-02-25 UA UA95083973A patent/UA48109C2/uk unknown
- 1994-02-25 RU RU95118404/13A patent/RU2219239C2/ru active
- 1994-02-25 CN CNB001377388A patent/CN1187450C/zh not_active Expired - Lifetime
- 1994-02-25 DK DK94909373T patent/DK0687296T3/da active
- 1994-02-25 BR BR9406376A patent/BR9406376A/pt not_active Application Discontinuation
- 1994-02-25 EP EP94909373A patent/EP0687296B1/en not_active Expired - Lifetime
- 1994-02-25 PT PT94909373T patent/PT687296E/pt unknown
- 1994-02-25 SG SG1996006564A patent/SG52597A1/en unknown
- 1994-02-25 KR KR1020017007711A patent/KR100357016B1/ko not_active Expired - Lifetime
- 1994-02-25 FI FI954082A patent/FI954082L/fi not_active IP Right Cessation
- 1994-02-25 WO PCT/SE1994/000160 patent/WO1994020610A1/en not_active Ceased
- 1994-02-25 AU AU62237/94A patent/AU675701B2/en not_active Expired
- 1994-02-25 JP JP51987494A patent/JP3837444B2/ja not_active Expired - Lifetime
- 1994-03-01 US US08/204,691 patent/US5827683A/en not_active Expired - Lifetime
- 1994-11-23 EE EE9400458A patent/EE9400458A/xx unknown
-
1995
- 1995-05-19 US US08/445,050 patent/US5763739A/en not_active Expired - Lifetime
- 1995-08-31 NO NO953426A patent/NO953426D0/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4130A (is) | Ný fjölpeptíð | |
| ATE317904T1 (de) | Überexpression von phytase in hefesystemen | |
| DK72593D0 (da) | Rekombinant protein | |
| DE69435049D1 (de) | Chimäre proteine zur vermeidung der komplementaktivierung | |
| HUP9801638A2 (hu) | Kevésbé adszorbeálódó és jobban hidrolizáló proteáz K variánsok | |
| AU3498189A (en) | Fibronectin binding protein | |
| WO2000006718A3 (en) | Expression of functional eukaryotic proteins | |
| HUP9900323A2 (hu) | Bakteriofág endoszialidáz aktivitással rendelkező rekombináns fehérje | |
| IL98273A0 (en) | Dna sequences,proteins having esterase activity coded by them,and use of such proteins | |
| IL89241A (en) | Recombinant vector comprising a dna segment encoding an enzyme having 2,5-diketogluconic acid(2,5-dkg)reductase activity | |
| ATE345382T1 (de) | 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung | |
| ATE380245T1 (de) | Gen von alteromonas | |
| DE69631127D1 (en) | Glykosyltransferase expression in aspergillus | |
| ZA91752B (en) | Process for the enzymatic cleavage or recombinant proteins using iga proteases | |
| KR950702204A (ko) | 크링글 함유 단백질 및 특히 t-PA의 정제(PURIFICATION OF KRINGLE CONTATINING PROTEINS AND ESPECIALLY t-PA) | |
| EP0497911A4 (en) | Recombinant production of lactoperoxidase | |
| AU2163588A (en) | Stabilization of enzymes by inhibiting proteolytic enzyme contaminants | |
| DE3878296D1 (de) | Rekombinante menschliche glutathionperoxidase, verfahren zur herstellung des enzyms und dafuer kodierende dna. | |
| ATE75255T1 (de) | Peptid und dafuer kodierendes gen. | |
| DK177591A (da) | Rekombinant humicola lipase | |
| ATE74378T1 (de) | Klonierung und charakterisierung des rinderinterleukin-2-gens. |